KLA Corp KLA.DE XETRA · Technology · United States
120.04 € -10.30% -13.78 €
Summary
75 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 36 USD is left as net profit.
- It earns 40 USD a year on every 100 USD of invested capital.
- It has raised its dividend 8 years in a row and pays out only 60% of profit.
- Analysts expect revenue to grow by 41% this fiscal year.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBy our assumptions the price matches the value of the business: the two differ by less than 10 %.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 35.5 USD for 1 USD of yearly profit. Over the last five years it was 36.9 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 9.0% a year. For the next fiscal year analysts expect revenue to grow by 41%. Earnings per share grew by 15% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 38 USD
- Research and development 11 USD
- Sales and administration 7.8 USD
- Taxes and other 7.7 USD
- Net profit 36 USD
Net profit, industry median (Semiconductors) 13 USD
Out of every 100 USD of revenue, 36 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 1.68%
- Paid out of profit
- 60%
- Raised in a row
- 8 years
You receive 2.21 € per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 25
- Hold 14
- Sell 2
No analyst has published a price target.
61% of the analysts recommend buying.
Analysts in detail